A 52-year-old male with severe rheumatoid arthritis and ankylosing spondylitis presents for elective lumbar spine fusion. On airway assessment, he has severely limited neck mobility (cervical fusion at C4–C5), mouth opening of 2 cm, and a Mallampati score of IV. Intubation with direct laryngoscopy is deemed high-risk. The anesthesiologist plans awake fiberoptic intubation. Which of the following is the MOST appropriate topical anesthetic agent and route for airway preparation in this patient?

Explanation

## Topical Anesthesia for Awake Fiberoptic Intubation **Key Point:** Awake fiberoptic intubation requires a two-level topical anesthetic strategy: oropharyngeal anesthesia (to suppress gag reflex and allow scope passage) and lower airway anesthesia (to suppress cough during intubation). ### Ideal Agents | Agent | Concentration | Route | Advantage | Disadvantage | |-------|---|---|---|---| | **Lidocaine** | 4% spray / 2% nebulized | Topical + inhalation | Rapid onset, safe, non-vasoconstrictive, allows visualization | Slower than cocaine | | **Cocaine** | 4–10% | Topical spray | Vasoconstrictive (↓ bleeding), rapid onset | Toxicity risk, sympathomimetic effects, contraindicated in hypertension/CAD | | **Benzocaine** | 20% spray | Topical only | Rapid onset | Risk of methemoglobinemia, no lower airway coverage | **High-Yield:** In this patient with **limited mouth opening and cervical fusion**, 4% lidocaine spray to the oropharynx + 2% lidocaine nebulized for the lower airway is the **gold standard**. It provides: - Adequate oropharyngeal anesthesia to suppress gag reflex - Lower airway anesthesia to suppress cough during scope passage and intubation - No vasoconstrictive effects (maintains visualization) - Safety profile superior to cocaine in a patient with potential cardiovascular comorbidities **Clinical Pearl:** Nebulized lidocaine (2–3 mL of 2% solution over 5–10 minutes) is preferred over IV lidocaine for lower airway anesthesia during fiberoptic intubation because it achieves direct mucosal contact and avoids systemic toxicity. ### Why This Patient Needs Both Levels With Mallampati IV and severely limited neck mobility, the anesthesiologist will need to manipulate the scope through the oropharynx and advance it into the larynx. Without lower airway anesthesia, the patient will cough violently during vocal cord passage, risking scope trauma and failed intubation. **Mnemonic:** **LIDOCAINE FIRST** — Lidocaine (topical) + Inhalation (nebulized) + Dexmedetomidine (sedation) = **LID** approach for awake FOI. [cite:Miller's Anesthesia 8e Ch 17]